INOVATYON
Trial Description:
Phase III international, randomized study of Trabectedin plus Pegylated Liposomal Doxorubicin (PLD) versus Carboplatin plus PLD in patients with ovarian cancer progressing within 6-12 months of last platinum
Lead Cooperative Group:
Trial Number:
Disease Site:
Recurrent Ovarian
Trial Status:
Completed
Contact person:
rfossati